Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 11 articles: HTML format Text format

Single Articles

January 2019
1. SU CT, Chau V, Halmos B, Shah CD, et al
   Impact of Primary Care Access on Mortality of Lung Cancer Patients in an Underserved Community.
   Am J Clin Oncol. 2019 Jan 16. doi: 10.1097/COC.0000000000000516.
   PubMed     Text format     Abstract available
   
   
   
2. MOORE S, Leung B, Wu J, Ho C, et al
   Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer.
   Am J Clin Oncol. 2019 Jan 2. doi: 10.1097/COC.0000000000000513.
   PubMed     Text format     Abstract available
   
   
   November 2018
3. RATHOD S, Koul R, Bashir B, Chowdhury A, et al
   Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening: A Systematic Review.
   Am J Clin Oncol. 2018 Nov 8. doi: 10.1097/COC.0000000000000489.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. KARANTH S, Rajan SS, Revere FL, Sharma G, et al
   Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
   Am J Clin Oncol. 2018 Oct 8. doi: 10.1097/COC.0000000000000485.
   PubMed     Text format     Abstract available
   
   
   September 2018
5. GIBSON AJW, Li H, D'Silva A, Tudor RA, et al
   Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.
   Am J Clin Oncol. 2018 Sep 11. doi: 10.1097/COC.0000000000000483.
   PubMed     Text format     Abstract available
   
   
   April 2018
6. TUMINELLO S, Liu B, Wolf A, Alpert N, et al
   Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques.
   Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000440.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. NIHO S, Ikeda N, Michimae H, Suzuki K, et al
   Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Resear
   Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000438.
   PubMed     Text format     Abstract available
   
   
   
8. LAFUENTE-SANCHIS A, Estors-Guerrero M, Zuniga A, Martinez-Hernandez NJ, et al
   Clinical Significance of Molecular Micrometastasis in the Sentinel Lymph Node of Early-stage Non-Small Cell Lung Cancer Patients.
   Am J Clin Oncol. 2018 Mar 5. doi: 10.1097/COC.0000000000000432.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. FIORICA F, Belluomini L, Stefanelli A, Santini A, et al
   Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination.
   Am J Clin Oncol. 2018 Jan 31. doi: 10.1097/COC.0000000000000428.
   PubMed     Text format     Abstract available
   
   
   November 2017
10. JEREMIC B
    Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).
    Am J Clin Oncol. 2017 Nov 7. doi: 10.1097/COC.0000000000000416.
    PubMed     Text format     Abstract available
    
    
    October 2017
11. YOSHIMURA N, Tada T, Matsumoto Y, Sawa K, et al
    Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Fin
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000412.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: